Ari Ristimaki
Affiliations: | Pathology and Lab Medicine | univ of helsinki |
Google:
"Ari Ristimaki"Mean distance: 12.31 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cvrljevic AN, Butt U, Huhtinen K, et al. (2022) Ovarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype. Molecular Cancer Therapeutics |
| Lähde M, Heino S, Högström J, et al. (2020) Expression of R-spondin1 in Apc Mice Reduces Growth of Intestinal Adenomas by Altering Wnt and TGFB Signaling. Gastroenterology |
| Holm M, Nummela P, Heiskanen A, et al. (2020) N-glycomic profiling of colorectal cancer according to tumor stage and location. Plos One. 15: e0234989 |
| Holm M, Joenväärä S, Saraswat M, et al. (2020) Plasma protein expression differs between colorectal cancer patients depending on primary tumor location. Cancer Medicine |
| Holm M, Joenväärä S, Saraswat M, et al. (2020) Preoperative Radiotherapy Leads to Significant Differences in the Plasma Protein Profile of Rectal Cancer Patients. Oncology. 1-8 |
| Osterlund E, Isoniemi H, Kytölä S, et al. (2020) SO-22 Atypical non-V600E BRAF (aBRAF) mutations as a prognostic and predictive factor in real-life metastatic colorectal cancer patients from the Nordic countries Annals of Oncology. 31 |
| Lasota J, Chłopek M, Lamoureux J, et al. (2019) Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature. The American Journal of Surgical Pathology |
| Cajuso T, Sulo P, Tanskanen T, et al. (2019) Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival. Nature Communications. 10: 4022 |
| Chakroborty D, Emani MR, Klén R, et al. (2019) L1TD1 - a prognostic marker for colon cancer. Bmc Cancer. 19: 727 |
| Kelppe J, Thorén H, Ristimäki A, et al. (2019) BRAF V600E expression in ameloblastomas - a 36 patient cohort from Helsinki University Hospital. Oral Diseases |